tiprankstipranks
Advertisement
Advertisement

GB:AVCT Stock Latest News

Avacta Files Six‑Monthly Block Listing Update for Employee Share Schemes
Company AnnouncementsAvacta Files Six‑Monthly Block Listing Update for Employee Share Schemes
8d ago
Avacta highlights tumor-targeted drug delivery gains as AVA6103 enters Phase 1
PremiumCompany Announcements
Avacta highlights tumor-targeted drug delivery gains as AVA6103 enters Phase 1
15d ago
Avacta CEO Named In Vivo Rising Leader as Oncology Platform Advances
PremiumCompany Announcements
Avacta CEO Named In Vivo Rising Leader as Oncology Platform Advances
22d ago
Avacta advances pre|CISION oncology pipeline and extends cash runway with £10m raise
PremiumCompany Announcements
Avacta advances pre|CISION oncology pipeline and extends cash runway with £10m raise
27d ago
Avacta to Showcase Next Chapter of pre|CISION Platform at 2026 Science Day
PremiumCompany Announcements
Avacta to Showcase Next Chapter of pre|CISION Platform at 2026 Science Day
28d ago
Avacta doses first patient in Phase 1 trial of new tumor-activated cancer drug AVA6103
PremiumCompany AnnouncementsAvacta doses first patient in Phase 1 trial of new tumor-activated cancer drug AVA6103
1M ago
Avacta Raises £10m in Oversubscribed Share Placing and Director Subscription
Premium
Company Announcements
Avacta Raises £10m in Oversubscribed Share Placing and Director Subscription
1M ago
Avacta launches £10m equity raise to extend runway and advance oncology pipeline
Premium
Company Announcements
Avacta launches £10m equity raise to extend runway and advance oncology pipeline
1M ago
Avacta raises £10m to extend runway and advance oncology pipeline
PremiumCompany Announcements
Avacta raises £10m to extend runway and advance oncology pipeline
1M ago
Avacta to Present New pre|CISION Cancer Drug Conjugate Data at 2026 AACR
PremiumCompany Announcements
Avacta to Present New pre|CISION Cancer Drug Conjugate Data at 2026 AACR
2M ago
Avacta opens Phase 1 trial for sustained-release tumor-targeted exatecan therapy
PremiumCompany Announcements
Avacta opens Phase 1 trial for sustained-release tumor-targeted exatecan therapy
2M ago
Avacta data show pre|CISION cancer drug outperforms leading ADC in preclinical analysis
PremiumCompany Announcements
Avacta data show pre|CISION cancer drug outperforms leading ADC in preclinical analysis
2M ago
Avacta to Spotlight Tumor-Targeted Oncology Platform at TD Cowen Conference
PremiumCompany AnnouncementsAvacta to Spotlight Tumor-Targeted Oncology Platform at TD Cowen Conference
3M ago
Avacta names Francis Wilson Chief Scientific Officer to drive pre|CISION® oncology platform
Premium
Company Announcements
Avacta names Francis Wilson Chief Scientific Officer to drive pre|CISION® oncology platform
3M ago
Avacta Lifts Dosing Cap and Sets Path to Efficacy Trials for Faridoxorubicin
Premium
Company Announcements
Avacta Lifts Dosing Cap and Sets Path to Efficacy Trials for Faridoxorubicin
3M ago
Avacta Wins FDA IND Clearance for Second pre|CISION® Cancer Drug AVA6103
PremiumCompany Announcements
Avacta Wins FDA IND Clearance for Second pre|CISION® Cancer Drug AVA6103
3M ago
Avacta Advances Tumor-Targeted Oncology Pipeline and Extends Cash Runway Into Q3 2026
PremiumCompany Announcements
Avacta Advances Tumor-Targeted Oncology Pipeline and Extends Cash Runway Into Q3 2026
4M ago
Avacta Names Strand Hanson as Nominated Adviser and Updates Share Capital and Governance Disclosures
PremiumCompany Announcements
Avacta Names Strand Hanson as Nominated Adviser and Updates Share Capital and Governance Disclosures
4M ago
Avacta Unveils Promising Data for Tumor-Targeted Cancer Therapy FAP-Exd
PremiumCompany Announcements
Avacta Unveils Promising Data for Tumor-Targeted Cancer Therapy FAP-Exd
5M ago
Avacta’s Faridoxorubicin Shows Promising Results in Salivary Gland Cancer Trials
PremiumCompany AnnouncementsAvacta’s Faridoxorubicin Shows Promising Results in Salivary Gland Cancer Trials
5M ago
Avacta Group Announces Preliminary Data in Salivary Gland Cancer Trial
Premium
Company Announcements
Avacta Group Announces Preliminary Data in Salivary Gland Cancer Trial
5M ago
Avacta Unveils Innovative Dual Payload Cancer Therapy
Premium
Company Announcements
Avacta Unveils Innovative Dual Payload Cancer Therapy
6M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >